Online citations, reference lists, and bibliographies.
← Back to Search

Production Of Solid Lipid Nanoparticles (SLN): Scaling Up Feasibilities

A. Dingler, S. Gohla
Published 2002 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Solid lipid nanoparticles (SLN/Lipopearls) are widely discussed as a new colloidal drug carrier system. In contrast to polymeric systems, such as Polylactic copolyol microcapsules, these systems show with a good biocompatibility, if applied parenterally. The solid lipid matrices can be comprised of fats or waxes, and allow protection of incorporated active ingredients against chemical and physical degradation. The SLN can either be produced by 'hot homogenization' of melted lipids at elevated temperatures or by a 'cold homogenization' process. This paper deals with production technologies for SLN formulations, based on non-ethoxylated fat components for topical application and high pressure homogenization. Based on the chosen fat components, a novel and easy manufacturing and scaling-up method was developed to maintain chemical and physical integrity of the encapsulated active ingredients in the carrier.
This paper references



This paper is referenced by
Nano Particulate Drug-Delivery Systems: An overview
Bandi Ramesh (2016)
10.1007/s11095-007-9514-y
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine
E. Esposito (2007)
10.1016/j.ijpharm.2009.07.025
Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles.
Gisele A. Castro (2009)
10.1504/IJBNN.2010.034654
Development of nanostructured lipid carriers (NLC) for controlled delivery of meloxicam
S. Khurana (2010)
10.1201/9781420008449.CH1
Nanoparticulate Drug-Delivery Systems: An Overview
Deepak Thassu (2007)
10.1002/9781119247159.CH5
Solid Lipid Nanoparticles
Jingyuan Wen (2018)
10.1211/0022357044959
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
10.1023/B:PHAM.0000041463.56768.ec
Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo
C. Rudolph (2004)
10.3762/bjnano.10.174
Lipid nanostructures for antioxidant delivery: a comparative preformulation study
E. Esposito (2019)
10.1016/S1773-2247(04)50080-1
Novel colloidal delivery systems for dermal application
M. Schubert (2004)
10.1016/S0378-5173(02)00587-2
Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles.
M. Oyewumi (2003)
Formulation, Optimization and In vitro Characterization of Letrozole Loaded Solid Lipid Nanoparticles
Archana Nerella (2014)
10.1002/9783527610419.NTLS0116
Solid Lipid and Polymeric Nanoparticles for Drug Delivery
J. Pedraz (2007)
10.1016/j.pnsc.2020.09.014
Development of a nano-immunomodulator encapsulating R837 and caffeine for combined radio-/immunotherapy against orthotopic breast cancer
Te-I Liu (2020)
Formulation of Nano Drug Delivery Systems
Luetfi (2011)
10.3390/nano9030474
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Laura Bayón-Cordero (2019)
10.1016/B978-0-323-52729-3.00002-0
Nanostructured lipid carriers
M. Shah (2017)
10.1016/J.JDDST.2018.03.010
Quality by design approach to screen the formulation and process variables influencing the characteristics of carvedilol solid lipid nanoparticles
K. Hosny (2018)
10.1002/9781118444726.CH4
Solid Lipid Nanoparticles for Drug Delivery
S. Joseph (2013)
10.1016/J.NANO.2005.06.004
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
10.1208/s12249-010-9563-0
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
S. Das (2010)
A SOLID LIPID NANOPARTICLE: AS NOVEL DRUG DELIVERY: AN OVERVIEW
S. D. Labhade (2015)
10.1016/B978-0-323-42868-2.00007-3
Nanobiomaterials in cosmetics: current status and future prospects
T. Singh (2016)
10.4062/biomolther.2017.095
Absorption Study of Genistein Using Solid Lipid Microparticles and Nanoparticles: Control of Oral Bioavailability by Particle Sizes
J. Kim (2017)
10.1016/j.canlet.2012.07.006
A critical review of lipid-based nanoparticles for taxane delivery.
L. Feng (2013)
10.1016/J.APT.2012.09.002
Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles
Madhu Burra (2013)
10.4018/978-1-4666-5125-8.CH071
Nanorevolution and Professionalizing University Education: Opportunities and Obstacles
M. Rai (2014)
PREPARATION AND EVALUATION OF CLOTRIMAZOLE NANOSTRUCTURED LIPID CARRIER FOR TOPICAL DELIVERY
Prachi B. Shekhawat (2013)
Comprehensive Review on Solid Lipid Nanoparticles
(2020)
10.1016/j.jconrel.2015.01.010
Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.
M. B. de Jesus (2015)
10.22270/jddt.v7i6.1523
TRANSDERMAL PATCH OF RAMIPRIL LOADED CHITOSAN NANOPARTICLES DISPERSED IN CARBOPOL GEL
Yerikala Ramesh (2017)
10.1504/IJBET.2009.022913
Nanostructured Lipid Carriers and their application in drug delivery
S. Khurana (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar